Semaglutide GLP-1 can help patients achieve a level of weight loss previously unattainable outside of invasive surgery
Patients can start seeing results within a few weeks, and these results can last long-term with continued treatment and lifestyle adjustments
Genetics, baseline skin tone, and treatment frequency all affect outcomes
Semaglutide Injection runs $189/mo ($2,268/year month-to-month, or $1,788/year on the 6-month plan), Tirzepatide Injection runs $289/mo ($3,468/year month-to-month, or $2,988/year on the 6-month plan), and GLP-Squared dual-compound is $289/mo
It has shown strong Phase III clinical results and represents a new generation of obesity therapies with improved efficacy and metabolic benefits